Prostate Cancer Clinical Trials in Pennsylvania

Showing 261-280 of 371 trials

Post-eRADicAte - A Long Term Follow up of Subjects That Completed the eRADicAte Study (NCT 02097303)

NCT03414437

This is a Long Term Follow Up study to eRADicAte, an open label study designed to examine the effects of Radium Ra 223 dichloride with concurrent administration of Abiraterone Acetate plus Prednisone Castrate-Resistant (Hormone-Refractory) Prostate Cancer subjects with symptomatic bone metastasis.

Prostate Cancer Metastatic

Carolina Research Professionals, LLC31 participantsStarted Oct 2017

Towson, Maryland, United States • Omaha, Nebraska, United States • Syracuse, New York, United States +2 more locations

COMPLETED90 miles

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

NCT00874211

RATIONALE: Gathering information about how often osteonecrosis of the jaw occurs in patients receiving zoledronic acid for bone metastases may help doctors learn more about the disease and provide the best follow-up care. PURPOSE: This clinical trial is studying osteonecrosis of the jaw in patients with cancer who are receiving zoledronic acid for bone metastases.

Breast CancerLung CancerMetastatic Cancer+4 more

SWOG Cancer Research Network3,571 participantsStarted Dec 2008

Anniston, Alabama, United States • Mobile, Alabama, United States • Anchorage, Alaska, United States +450 more locations

Post-eRADicAte - A Long Term Follow up of Subjects That Completed the eRADicAte Study (NCT 02097303)

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Prostate Cancer Trials in Other Cities

ClariCore System Used in Transperineal Prostate Biopsy

Prospective CiRculating prOstate Cancer Predictors in HighEr Risk mCRPC studY

Intraprostatic PRX302 Injection to Treat Localised Prostate Cancer

Sirolimus Before Surgery in Treating Patients With Advanced Localized Prostate Cancer

ClariCore System Used in Transrectal Ultrasound Guided Prostate Biopsy for Real-Time Tissue Evaluation

ClariCore Optical Biopsy System Used in TRUS (Trans-Rectal Ultrasound)-Guided Prostrate Biopsy

ClariCore™ Biopsy System in Patients Undergoing Radical Retropubic Prostatectomy

Cabazitaxel Versus the Switch to Alternative AR Targeted Therapy Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Primary Resistant Patients to Abiraterone or Enzalutamide

Multi-Institutional Registry for Prostate Cancer Radiosurgery

AMG 386 and Abiraterone for Advanced Prostate Cancer

Vaccine Therapy With PROSTVAC/TRICOM and Flutamide Versus Flutamide Alone to Treat Prostate Cancer

A Multicenter Clinical Study of the Sonablate®450 for the TreAtment of Locally Recurrent Prostate Cancer With HIFU (STAR Trial)

A Study to Evaluate Oral VT-464 in Patients With Castration-Resistant Prostate Cancer

Cixutumumab and Temsirolimus in Treating Patients With Metastatic Prostate Cancer

Safety and Tolerability Study of MDV3100 in Combination With Docetaxel in Men With Advanced Prostate Cancer

EXTEND Exercise Trial

Once-daily Oral Seviteronel in Patients With Castration-Resistant Prostate Cancer Progressing on Enzalutamide or Abiraterone.

Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors

Other Conditions in Pennsylvania